Cargando…

Smoking is associated with pneumonia development in lung cancer patients

BACKGROUND: Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radiotherapy, and surgical intervention are limited. Thus, the purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Jung Won, Yeo, Chang Dong, Park, Chan Kwon, Kim, Sung Kyoung, Kim, Ju Sang, Kim, Jin Woo, Kim, Seung Joon, Lee, Sang Haak, Kang, Hye Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195765/
https://www.ncbi.nlm.nih.gov/pubmed/32357887
http://dx.doi.org/10.1186/s12890-020-1160-8
_version_ 1783528604978642944
author Heo, Jung Won
Yeo, Chang Dong
Park, Chan Kwon
Kim, Sung Kyoung
Kim, Ju Sang
Kim, Jin Woo
Kim, Seung Joon
Lee, Sang Haak
Kang, Hye Seon
author_facet Heo, Jung Won
Yeo, Chang Dong
Park, Chan Kwon
Kim, Sung Kyoung
Kim, Ju Sang
Kim, Jin Woo
Kim, Seung Joon
Lee, Sang Haak
Kang, Hye Seon
author_sort Heo, Jung Won
collection PubMed
description BACKGROUND: Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radiotherapy, and surgical intervention are limited. Thus, the purpose of this study was to identify risk factors for pneumonia development in lung cancer patients. METHODS: The present study used a lung cancer cohort of the Catholic Medical Center at the Catholic University of Korea from January 2015 to December 2018. Pneumonia was defined by the presence of a new or progressive infiltration on chest imaging together with any of the following: new onset purulent sputum, change in character of chronic sputum, and fever. We ruled out noninfectious infiltration such as drug or radiation toxicity and hydrostatic pulmonary edema. We especially excluded those if computed tomography revealed sharp demarcation consolidation or ground glass opacity limited radiation field. RESULTS: A total of 413 patients were enrolled in this study. Pneumonia occurred in 118 (28.6%) patients. The pneumonia group had significantly worse overall survival (OS) than the non-pneumonia group (456.7 ± 35.0 days vs. 813.4 ± 36.1 days, log rank p < 0.001). In patients with pneumonia, OS was shorter in ex-smokers and current smokers than in never smokers (592.0 ± 101.0 days vs. 737.0 ± 102.8 days vs. 1357.0 days, log rank p < 0.001). Age (hazard ratio [HR]: 1.046; 95% confidence interval [CI]: 1.019–1.074; p = 0.001), clinical stage IV (HR: 1.759; 95% CI: 1.004–3.083; p = 0.048), neutropenia (HR: 2.620; 95% CI: 1.562–4.396; p < 0.001], and smoking (HR: 2.040; 95% CI: 1.100–3.784; p = 0.024) were independent risk factors of pneumonia development in lung cancer patients in multivariate analysis. In subgroup analysis for patients treated with chemotherapy, age (HR: 1.043; 95% CI: 1.012–1.074; p = 0.006), neutropenia (HR: 3.199; 95% CI: 1.826–5.605; p < 0.001), and smoking (HR: 2.125; 95% CI: 1.071–4.216; p = 0.031) were independent risk factors of pneumonia development. CONCLUSIONS: Smoking and neutropenia were risk factors affecting pneumonia development in the total group and subgroup of patients with lung cancer.
format Online
Article
Text
id pubmed-7195765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71957652020-05-06 Smoking is associated with pneumonia development in lung cancer patients Heo, Jung Won Yeo, Chang Dong Park, Chan Kwon Kim, Sung Kyoung Kim, Ju Sang Kim, Jin Woo Kim, Seung Joon Lee, Sang Haak Kang, Hye Seon BMC Pulm Med Research Article BACKGROUND: Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radiotherapy, and surgical intervention are limited. Thus, the purpose of this study was to identify risk factors for pneumonia development in lung cancer patients. METHODS: The present study used a lung cancer cohort of the Catholic Medical Center at the Catholic University of Korea from January 2015 to December 2018. Pneumonia was defined by the presence of a new or progressive infiltration on chest imaging together with any of the following: new onset purulent sputum, change in character of chronic sputum, and fever. We ruled out noninfectious infiltration such as drug or radiation toxicity and hydrostatic pulmonary edema. We especially excluded those if computed tomography revealed sharp demarcation consolidation or ground glass opacity limited radiation field. RESULTS: A total of 413 patients were enrolled in this study. Pneumonia occurred in 118 (28.6%) patients. The pneumonia group had significantly worse overall survival (OS) than the non-pneumonia group (456.7 ± 35.0 days vs. 813.4 ± 36.1 days, log rank p < 0.001). In patients with pneumonia, OS was shorter in ex-smokers and current smokers than in never smokers (592.0 ± 101.0 days vs. 737.0 ± 102.8 days vs. 1357.0 days, log rank p < 0.001). Age (hazard ratio [HR]: 1.046; 95% confidence interval [CI]: 1.019–1.074; p = 0.001), clinical stage IV (HR: 1.759; 95% CI: 1.004–3.083; p = 0.048), neutropenia (HR: 2.620; 95% CI: 1.562–4.396; p < 0.001], and smoking (HR: 2.040; 95% CI: 1.100–3.784; p = 0.024) were independent risk factors of pneumonia development in lung cancer patients in multivariate analysis. In subgroup analysis for patients treated with chemotherapy, age (HR: 1.043; 95% CI: 1.012–1.074; p = 0.006), neutropenia (HR: 3.199; 95% CI: 1.826–5.605; p < 0.001), and smoking (HR: 2.125; 95% CI: 1.071–4.216; p = 0.031) were independent risk factors of pneumonia development. CONCLUSIONS: Smoking and neutropenia were risk factors affecting pneumonia development in the total group and subgroup of patients with lung cancer. BioMed Central 2020-05-01 /pmc/articles/PMC7195765/ /pubmed/32357887 http://dx.doi.org/10.1186/s12890-020-1160-8 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Heo, Jung Won
Yeo, Chang Dong
Park, Chan Kwon
Kim, Sung Kyoung
Kim, Ju Sang
Kim, Jin Woo
Kim, Seung Joon
Lee, Sang Haak
Kang, Hye Seon
Smoking is associated with pneumonia development in lung cancer patients
title Smoking is associated with pneumonia development in lung cancer patients
title_full Smoking is associated with pneumonia development in lung cancer patients
title_fullStr Smoking is associated with pneumonia development in lung cancer patients
title_full_unstemmed Smoking is associated with pneumonia development in lung cancer patients
title_short Smoking is associated with pneumonia development in lung cancer patients
title_sort smoking is associated with pneumonia development in lung cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195765/
https://www.ncbi.nlm.nih.gov/pubmed/32357887
http://dx.doi.org/10.1186/s12890-020-1160-8
work_keys_str_mv AT heojungwon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT yeochangdong smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT parkchankwon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT kimsungkyoung smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT kimjusang smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT kimjinwoo smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT kimseungjoon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT leesanghaak smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients
AT kanghyeseon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients